Parkman Healthcare Partners’s Avantor AVTR Stock Holding History

Parkman Healthcare Partners’s Portfolio AVTR Stock Details AVTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-172,269	Closed	-$5.36M	–	92
2022 Q2	$5.36M	Buy	172,269 +13,904	+9%	+$434K	1.97%	17
2022 Q1	$5.36M	Sell	158,365 -249,210	-61%	-$8.89M	1.57%	22
2021 Q4	$17.2M	Sell	407,575 -32,425	-7%	-$1.28M	3.79%	6
2021 Q3	$18M	Buy	440,000 +86,059	+24%	+$3.36M	4.55%	3
2021 Q2	$12.6M	Buy	353,941 +101,778	+40%	+$3.29M	2.75%	11
2021 Q1	$7.29M	Buy	252,163 +101,291	+67%	+$2.92M	1.69%	20
2020 Q4	$4.25M	Buy	+150,872	New	+$3.89M	1.09%	37

Other funds holding AVTR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

NMC

New Mountain Capital New York $110M AUM 51.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Parkman Healthcare Partners's AVTR Position: Q3 2022 in Review

Parkman Healthcare Partners sold out of Avantor (AVTR) in Q3 2022, closing a stake of 172,269 shares — an estimated $5.36M sold.

Parkman Healthcare Partners first reported a position in AVTR in Q4 2020 and held it in 7 quarters. The position peaked at $18M in Q3 2021. 440 funds tracked by Wall St. Rank hold AVTR as of Q3 2022.

Parkman Healthcare Partners reported no remaining Avantor position as of Q3 2022 after selling out during the quarter.
Parkman Healthcare Partners sold 172,269 Avantor shares in Q3 2022, an estimated $5.36M.
Parkman Healthcare Partners first reported a position in Avantor in Q4 2020 and held it in 7 quarters.
Parkman Healthcare Partners's Avantor position peaked at $18M in Q3 2021.
440 funds tracked by Wall St. Rank held Avantor as of Q3 2022.

Based on Parkman Healthcare Partners's 13F filing for Q3 2022, filed 14 Nov 2022.